Action Lab A: What Are the Implications of Redesigned Work on Roles, Capabilities, & Org Design Across the R&D Value Chain to Drive Innovation?

10:50 am - Thursday 3rd December 2026

  • What new skills and capabilities will be needed as AI reshapes work across the R&D value chain (namely across discovery, clinical and CMC/operational functions)?
  • How should organizations approach upskilling, reskilling, and workforce planning where domainspecific, scientific or technical expertise remains critical?
  • What role-specific capability gaps must be addressed to enable effective human-AI collaboration and accelerate innovation in these functions specifically?

Speakers:

Strategic Advisor, most recently Executive Vice President of Human Resources
Regeneron Pharmaceuticals
Vice President, Global Head of Human Resources, R&D & Enabling Functions
CSL